Biblio Discovery — Demo Discovery Service

10 hasil untuk "Toby Pepperrell"

Menampilkan 1–10 · 3,67 detik · RSS

  1. Artikel Jurnal

    A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?

    Victoria Pilkington; Toby Pepperrell; Andrew Hill

    Journal of Virus Eradication, Vol. 6 No. 2 · 2020 · Inggris · DOAJ Scopus

    Background: Repurposing broad-spectrum antivirals is an immediate treatment opportunity for 2019 coronavirus disease (COVID-19). Favipiravir is an antiviral previously indicated for influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19. We aim to review…

    Juga tersedia di: OpenAlex

  2. Artikel Jurnal

    Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs

    Florence Rodgers; Toby Pepperrell; Sarai Keestra dkk.

    Trials, Vol. 22 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Several drugs are being repurposed for the treatment of the coronavirus disease 2019 (COVID-19) pandemic based on in vitro or early clinical findings. As these drugs are being used in varied regimens and dosages, it is important to enable synthesis of existing safety data from…

  3. Artikel Jurnal Teks lengkap

    Transforming trade for vaccine equity: Policy gaps and barriers.

    Toby Pepperrell; Meri Koivusalo; Liz Grant dkk.

    PLOS Global Public Health, Vol. 5 No. 6 · 2025 · Inggris · DOAJ Scopus

    The ongoing Pandemic Agreement negotiations illustrate significant gaps in action required to respond effectively to the lessons of the COVID-19 pandemic and make progress towards public health goals, including Sustainable Development Goals (SDGs). The pandemic revealed vaccine equity as a unifying…

    Juga tersedia di: DOAJ, PLOS

  4. Artikel Jurnal

    Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19

    Toby Pepperrell; Victoria Pilkington; Andrew Owen dkk.

    Journal of Virus Eradication, Vol. 6 No. 2 · 2020 · Inggris · DOAJ Scopus

    Background: Many treatments are being assessed for repurposing to treat coronavirus disease 2019 (COVID-19). One drug that has shown promising results in vitro is nitazoxanide. Unlike other postulated drugs, nitazoxanide shows a high ratio of maximum plasma concentration (Cmax), after 1 day of 500…

  5. Artikel Jurnal

    Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials

    Toby Pepperrell; Florence Rodgers; Pranav Tandon dkk.

    Global Health Action, Vol. 14 No. 1 · 2021 · Inggris · DOAJ Scopus

    Coronavirus disease 2019 (COVID-19) mortality and morbidity have been shown to increase with deprivation and impact non-White ethnicities more severely. Despite the extra risk Black, Asian and Minority Ethnicity (BAME) groups face in the pandemic, our current medical research system seems to…

  6. Artikel Jurnal

    Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic

    Toby Pepperrell; Andrew Hill; Michelle Moorhouse dkk.

    Journal of Virus Eradication, Vol. 6 No. 2 · 2020 · Inggris · DOAJ Scopus

    Introduction: People living with HIV (PLWH) are mainly African or Asian, the majority female. In contrast, pharmaceutical companies typically conduct phase 3 regulatory randomised controlled trials (RCTs) in high-income countries (HICs), where PLWH are mainly white males. Regulatory authorities can…

  7. Artikel Jurnal

    Risks of metabolic syndrome in the ADVANCE and NAMSAL trials

    Tamara Tovar Sanchez; Mireille Mpoudi-Etame; Charles Kouanfack dkk.

    Frontiers in Reproductive Health, Vol. 5 · 2023 · Inggris · DOAJ Scopus

    IntroductionThe ADVANCE and NAMSAL trials evaluating antiretroviral drugs have both reported substantial levels of clinical obesity in participants. As one of the main risk factors for metabolic syndrome, growing rates of obesity may drive metabolic syndrome development. This study aims to evaluate…